levornidazole 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definitionDrug idCAS RN
antiprotozoals and radiosensitizers, metronidazole derivatives 5254 166734-83-4

Description:

MoleculeDescription

Molfile Inchi Smiles

Synonyms:

  • levornidazole
  • Levo-ornidazole
  • L-Ornidazole
Levornidazole is a nitroimidazole derivative, which is mediated through the reduction in anaerobic environment into amino or the formation of free radicals from the nitro, interacting with celluar components, results in the death of microorganisms. It is indicated for the treatment of a variety of infectious diseases caused by sensitive anaerobic bacteria.
  • Molecular weight: 217.65
  • Formula: C8H12ClN3O2
  • CLOGP: 1.69
  • LIPINSKI: 0
  • HAC: 5
  • HDO: 0
  • TPSA: 60.96
  • ALOGS: -2.35
  • ROTB: 4

Drug dosage:

None

ADMET properties:

None

Approvals:

DateAgencyCompanyOrphan
Aug. 13, 2009 China Food and Drug Administration (CFDA) Sanhome

FDA Adverse Event Reporting System (Female)

None

FDA Adverse Event Reporting System (Male)

None

FDA Adverse Event Reporting System (Geriatric)

None

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

None

Drug Use | Suggest Off label Use Form| |View source of the data|

None




🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

Dissociation levelDissociation constantType (acidic/basic)
pKa1 2.67 Basic

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

None

External reference:

IDSource
C5226952 UMLSCUI
6541429 PUBCHEM_CID
C000634527 MESH_SUPPLEMENTAL_RECORD_UI

Pharmaceutical products:

None